Abstract
Actinomycetes are among the most fascinating microorganisms. Their developmental life cycle with its morphological and physiological differentiation and the rich repertoire of secondary metabolites (about 70-80% of bioactive secondary metabolites are being produced by actinomycetes) have resulted in a large research community studying these microbes. Of particular interest are actinomycetes for large-scale industrial production of bioactive molecules, such as polyketides, representing a diverse class of such compounds, including molecules with anticancer activity (e.g., mithramycin, daunorubicin, doxorubicin), antibacterials (e.g., erythromycin and derivatives or tetracyclines), antiparasitics (avermectins), or immunosuppressants (rapamycin). The biotechnological process for erythromycin production is described.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kieser, T., Bibb, J., Buttner, M. J., Chaiter, K. E, and Hopwood, D. A. (eds.) (2000) Practial Streptomyces Genetics, The John Innes Foundation, Norwich, UK.
Demain, A. L. (1989) Function of secondary metabolites, in Genetics and Molecular Biology of Industrial Microorganisms (Hershberger, C. L., Queener, S. W., and Hegemann, eds.), American Society for Microbiology, Washington DC, pp. 1–11.
Vining, L. C. and Stuttad, C. (ds.) (1995) Genetics and Biochemistry of Antibiotic Production, Butterworth-Heinemann, Boston, MA.
Dimroth, P., Walter, H., and Lynen, F. (1970) Biosynthesis of 6-methylsalicylic acid. Eur. J. Biochem. 13, 98–110.
O’Hagan, D. (ed.) (1991) The Polyketide Metabolites. Ellis Horwood, London.
Reimold, U., Kröger, M., Kreuzaler, F., and Hahlbrock, K. (1983) Coding and 3 non-coding nucleotide sequence of chalcone synthase mRNA and assignment of amino acid sequence of the enzyme. EMBO J. 2, 1801–1805.
Katz, L. and Donadio, S. (1993) Polyketide synthesis: prospects for hybrid antibiotics. Annu. Rev. Microbiol. 47, 875–912.
Katz, L. (1997) Manipulation of modular polyketide synthases. Chem. Rev. 97, 2557–2576.
Staunton, J. and Wilkinson, B. (1997) Biosynthesis of erythromycin and rapamycin. Chem. Rev. 97, 2611–2630.
Malpartida, E and Hopwood, D. A. (1986) Physical and genetic characterisation of the gene cluster for the antibiotic actinorhodin in Streptomyces coelicolor A3(2). Mol. Gen. Genet. 205, 66–73.
Viollier, P. H. Minas, W., Dale, G. E., Folcher, M., and Thompson, C. J. (2001) Roles of aconitase in growth, metabolism, and morphological differentiation of Streptomyces coelicolor. J. Bacteriol. 183, 3193–3203.
Kelemen, G. H. Viollier, P. H., Tenor, J., Marri, L., Buttner, M. J., and Thompson, C. J. (2001) A connection between stress and development in the multicellular prokaryote Streptomyces coelicolor A3(2). Mol. Microbiol. 40, 804–814.
Vohradsky, J. Li, X., Dale, G., et al. (2000) Developmental control of stress stimu-lons in Streptomyces coelicolor revealed by statistical analyses of global gene expression patterns. J. Bacteriol. 182, 4979–4986.
Yamazaki, H., Ohnishi, Y., and Horinouchi, S. (2000) An A-factor-dependent extra-cytoplasmic function sigma factor (σAdsA) that is essential for morphological development in Streptomyces griseus. J. Bacteriol. 182, 4596–4605.
Ueda, K., Kawai, S., Ogawa, H.-O., et al. (2000) Wide distribution of interspecific stimulatory events on antibiotic production and sporulation among Streptomyces species. J. Antibiot. 53, 979–982.
Waksman, S. A. (ed.) (1947) Microbial Antagonisms and Antibiotic Substances. Commonwealth Fund, New York.
Bunch, R. L., and McGuire, J. M. (1953) US patent 2653899 (to Eli Lilly Co.).
Brunker, P., Minas, W., Kallio, P. T., and Bailey, J. E. (1998) Genetic engineering of an industrial strain of Saccharopolyspora erythraea for stable expression of the Vitreoscilla haemoglobin gene (vhb). Microbiology 144(Pt. 9), 2441–2448.
Minas, W., Brünker, P., Kallio, P. T., and Bailey, J. E. (1998) Improved erythromy-cin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol. Prog. 14, 561–566.
Ausubel, F., Brent, R., Kingston, R. E., et al. (eds.) (1989) Short Protocols in Molecular Biology, Wiley & Sons, New York, USA.
Gerhardt, B., Murray, R. G. E., Wood, W. A., and Krieg, N. R. (eds.) (1994) Manual of the Methods for General Bacteriology, American Society for Microbiology, Washington, DC.
Tsuji, K. and Goetz, J. F. (1978) High-performance liquid chromatographic determination of erythromycin. J. Chromatogr. 147, 359–367.
Tamburasov, Z. and Djokic, S. (1969) British patent GB 1100504 (to Pliva Pharm & Chem Works.).
Djokic, S. and Kobrehel, G. (1985) British patent GB 2094293 (to Pliva Pharm & Chem Works.).
Bright, G. M. (1984) European patent EP0101186 (to Pfizer).
Flynn, E. H., Murphy, H. W., and McMahon, R. E. (1955) Erythromycin. II. Des-N-methylerythromycin and N-Methyl-C14-erythromycin. J. Am. Chem. Soc. 77, 3104–3106.
Gouin d’Ambrieres, S., Lutz, A., and J.-C., G. (1982) French patent FR2473525 (to Roussel UCLAF).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Minas, W. (2005). Production of Erythromycin With Saccharopolyspora erythraea . In: Barredo, JL. (eds) Microbial Processes and Products. Methods in Biotechnology, vol 18. Humana Press. https://doi.org/10.1385/1-59259-847-1:065
Download citation
DOI: https://doi.org/10.1385/1-59259-847-1:065
Publisher Name: Humana Press
Print ISBN: 978-1-58829-548-4
Online ISBN: 978-1-59259-847-2
eBook Packages: Springer Protocols